SGRY — Surgery Partners to pay $108.9M termination fee to Spyglass Topco under merger agreement

The confirmed event

Trading outlets carried a Reuters report saying Surgery Partners, Inc. (SGRY) has agreed in its merger paperwork to pay Spyglass Topco a termination fee of $108.9 million if the merger agreement is terminated under specified circumstances. The report is published via TradingView and is listed in SMC’s current news digest.

Sources: S1 · S2

Why it matters

The termination‑fee clause is a material, deal‑level term: it creates a defined cash obligation for SGRY if the transaction fails under the outlined conditions and is an incremental disclosure following same‑day acquisition reporting. SMC’s current digest also includes a same‑day item that HealthSpan Partners will acquire Surgery Partners in a $5.7 billion deal, so the termination‑fee detail refines the known M&A terms for the company.

Sources: S2 · S1

What we don’t see in the market data

The supplied market data include the Reuters/TradingView report and same‑day acquisition coverage but do not contain the full merger agreement, an issuer press release or an SEC filing with the termination‑trigger language. The precise circumstances that trigger the $108.9 million fee are not in the available text.

Sources: S1 · S2

What remains uncertain

• Full merger agreement text or a company press release/SEC filing is not included in the supplied market data — exact termination triggers and timing details are unavailable here.
• No market‑price or trading reaction data for SGRY is provided in the available market data; this briefing only reports the announced contractual term as captured by Reuters/TradingView.